About Gregor Diagnostics
Gregor Diagnostics is a molecular diagnostics company developing non-invasive, semen-based screening tests for prostate cancer. Its proprietary assay analyzes seminal fluid for cancer-associated biomarkers to detect prostate cancer early and differentiate between indolent and aggressive forms, serving men undergoing prostate cancer screening or active surveillance.
Company details
Funding
Total raised
$14.6M
Last stage
Series A
Investors
Founders
Tobias Zutz
Tobias Zutz is the CTO and Founder of Gregor Diagnostics, a molecular diagnostics company developing a novel screening test for prostate cancer using seminal fluid. He licensed the technology from WARF to found the company.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.